10 studies found for:    E1505
Show Display Options
Rank Status Study
1 Active, not recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-Small Cell Lung Carcinoma;   Stage IIA Non-Small Cell Lung Carcinoma;   Stage IIB Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer
Interventions: Drug: Gemcitabine Hydrochloride;   Drug: Vinorelbine Tartrate;   Drug: Cisplatin;   Drug: Docetaxel;   Drug: Pemetrexed Disodium;   Biological: Bevacizumab;   Other: Questionnaire Administration;   Other: Laboratory Biomarker Analysis
2 Recruiting Exercise Education for Adults With Seizure Disorders
Conditions: Seizures;   Epilepsy
Intervention: Other: Patient Education
3 Active, not recruiting A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain
Condition: Endometriosis
Interventions: Drug: ASP1707;   Drug: Placebo;   Drug: Leuprorelin acetate
4 Completed Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Biological: bevacizumab;   Drug: vinorelbine tartrate
5 Completed
Has Results
Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium;   Drug: placebo
6 Completed
Has Results
Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Stroke
Interventions: Drug: warfarin;   Drug: Dabigatran dose 1;   Drug: Dabigatran dose 2
7 Completed Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: irinotecan hydrochloride;   Drug: pemetrexed disodium
8 Completed
Has Results
RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial
Condition: Atrial Fibrillation
Interventions: Drug: dabigatran dose 1;   Drug: dabigatran dose 2
9 Completed
Has Results
Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
10 Recruiting Self-management to Improve Function Following Amputation
Condition: Amputation, Limb Loss
Interventions: Behavioral: VETPALS;   Behavioral: Individual Education Support Program

Indicates status has not been verified in more than two years